Free Trial

STERIS (STE) Financials

STERIS logo
$246.29 +3.29 (+1.35%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$246.20 -0.09 (-0.04%)
As of 05/27/2025 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for STERIS

Annual Income Statements for STERIS

This table shows STERIS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020 3/31/2019 3/31/2018 3/31/2017
Net Income / (Loss) Attributable to Common Shareholders
378 107 244 397 408 304 291 110
Consolidated Net Income / (Loss)
380 106 243 397 408 305 292 111
Net Income / (Loss) Continuing Operations
553 556 284 397 408 305 292 111
Total Pre-Tax Income
703 680 367 518 499 369 355 185
Total Operating Income
836 791 478 548 537 411 400 226
Total Gross Profit
2,218 1,981 1,883 1,343 1,320 1,175 1,093 1,026
Total Revenue
5,139 4,536 4,223 3,108 3,031 2,782 2,620 2,613
Operating Revenue
5,139 4,536 4,223 3,108 3,031 2,782 2,620 2,613
Total Cost of Revenue
2,921 2,556 2,340 1,764 1,711 1,607 1,527 1,587
Operating Cost of Revenue
2,921 2,556 2,340 1,764 1,711 1,607 1,527 1,587
Total Operating Expenses
1,382 1,190 1,405 795 783 764 693 800
Selling, General & Admin Expense
1,252 1,091 1,318 731 717 670 632 682
Research & Development Expense
104 98 87 66 66 63 61 59
Restructuring Charge
26 0.49 0.05 -2.91 0.67 31 0.10 0.22
Total Other Income / (Expense), net
-133 -111 -111 -31 -38 -42 -45 -42
Interest Expense
144 108 89 37 40 45 51 45
Other Income / (Expense), net
11 -2.88 -22 6.35 1.99 3.02 5.73 2.96
Income Tax Expense
150 124 82 121 91 64 63 74
Net Income / (Loss) Discontinued Operations
-173 -450 -42 - - - - -
Net Income / (Loss) Attributable to Noncontrolling Interest
1.84 -1.22 -1.02 -0.53 0.20 1.03 0.71 0.67
Basic Earnings per Share
$3.83 $1.07 $2.50 $4.66 $4.81 $3.59 $3.42 $1.29
Weighted Average Basic Shares Outstanding
197.80M 197.30M 200.16M 170.74M 84.92M 84.54M - -
Diluted Earnings per Share
$3.81 $1.07 $2.48 $4.63 $4.76 $3.55 $3.39 $1.28
Weighted Average Diluted Shares Outstanding
197.80M 197.30M 200.16M 170.74M 84.92M 84.54M - -
Weighted Average Basic & Diluted Shares Outstanding
197.80M 197.30M 200.16M 170.74M 84.92M 84.54M - -
Cash Dividends to Common per Share
$2.03 $1.84 $1.69 $1.57 $1.45 $1.33 $1.21 $1.09

Quarterly Income Statements for STERIS

This table shows STERIS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022
Net Income / (Loss) Attributable to Common Shareholders
174 150 145 -1.38 141 115 124 187 124 -315 111
Consolidated Net Income / (Loss)
173 151 146 -1.00 141 116 124 187 123 -315 111
Net Income / (Loss) Continuing Operations
173 151 140 172 149 121 131 637 123 -315 111
Total Pre-Tax Income
229 195 175 215 190 156 167 718 160 -333 135
Total Operating Income
245 220 186 245 226 192 198 748 191 -306 158
Total Gross Profit
610 579 572 449 560 546 529 409 521 532 518
Total Revenue
1,371 1,329 1,280 1,116 1,298 1,238 1,183 963 1,216 1,201 1,156
Operating Revenue
1,371 1,329 1,280 1,116 1,298 1,238 1,183 963 1,216 1,201 1,156
Total Cost of Revenue
760 750 707 668 738 692 654 554 694 668 639
Operating Cost of Revenue
760 750 707 668 738 692 654 554 694 668 639
Total Operating Expenses
365 359 387 203 334 355 331 -339 331 839 359
Selling, General & Admin Expense
335 329 336 152 308 328 307 128 305 323 335
Research & Development Expense
27 27 26 25 25 26 25 23 26 25 25
Restructuring Charge
2.23 2.80 26 26 0.01 -0.02 0.02 0.36 0.04 0.06 0.03
Total Other Income / (Expense), net
-17 -25 -10 -30 -37 -36 -31 -30 -30 -27 -23
Interest Expense
19 20 30 36 39 37 32 31 29 26 23
Other Income / (Expense), net
2.55 -5.11 20 6.33 2.08 1.24 1.38 0.32 -1.91 -0.52 -0.77
Income Tax Expense
55 44 35 43 41 35 36 81 37 -18 24
Net Income / (Loss) Discontinued Operations
-0.08 -0.21 5.59 - -7.66 -4.45 -6.79 - - - -
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.25 1.14 0.14 0.38 0.20 1.03 0.24 -0.26 -0.50 0.05 -0.51
Basic Earnings per Share
$1.76 $1.52 $1.47 ($0.01) $1.42 $1.17 $1.25 $1.87 $1.24 ($3.15) $1.11
Weighted Average Basic Shares Outstanding
98.25M 98.71M 197.23M 197.80M 197.63M 197.60M 197.56M 197.30M 198.57M 199.65M 200.03M
Diluted Earnings per Share
$1.75 $1.51 $1.46 ($0.02) $1.42 $1.16 $1.25 $1.88 $1.24 ($3.15) $1.10
Weighted Average Diluted Shares Outstanding
98.25M 98.71M 197.23M 197.80M 197.63M 197.60M 197.56M 197.30M 198.57M 199.65M 200.03M
Weighted Average Basic & Diluted Shares Outstanding
98.25M 98.71M 197.23M 197.80M 197.63M 197.60M 197.56M 197.30M 198.57M 199.65M 200.03M
Cash Dividends to Common per Share
$0.57 $0.57 $0.52 $0.52 $0.52 $0.52 $0.47 $0.47 $0.47 $0.47 $0.43

Annual Cash Flow Statements for STERIS

This table details how cash moves in and out of STERIS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020 3/31/2019 3/31/2018 3/31/2017
Net Change in Cash & Equivalents
-1.34 -140 128 -99 99 19 -81 34
Net Cash From Operating Activities
973 757 685 690 591 540 458 424
Net Cash From Continuing Operating Activities
973 750 685 690 591 540 458 424
Net Income / (Loss) Continuing Operations
380 106 243 397 408 305 292 111
Consolidated Net Income / (Loss)
380 106 243 397 408 305 292 111
Depreciation Expense
565 553 553 219 197 226 178 188
Amortization Expense
4.82 - 67 0.00 0.00 - - -
Non-Cash Adjustments To Reconcile Net Income
301 527 78 50 26 5.12 72 151
Changes in Operating Assets and Liabilities, net
-277 -436 -256 23 -40 3.72 -84 -26
Net Cash From Investing Activities
-887 -383 -667 -1,154 -320 -213 -204 -104
Net Cash From Continuing Investing Activities
-887 -383 -667 -1,154 -320 -213 -204 -104
Purchase of Property, Plant & Equipment
-360 -362 -288 -239 -215 -190 -165 -173
Acquisitions
-546 -43 -550 -909 -110 -13 -46 -66
Purchase of Investments
-1.50 0.00 0.00 -4.40 0.00 -4.96 0.00 -6.36
Sale of Property, Plant & Equipment
7.38 15 1.74 0.57 4.16 5.57 2.09 4.85
Divestitures
9.46 6.62 170 0.52 0.44 2.48 8.89 136
Sale and/or Maturity of Investments
3.88 0.00 - - - - - -
Net Cash From Financing Activities
-85 -499 116 346 -163 -295 -356 -267
Net Cash From Continuing Financing Activities
-85 -499 116 346 -163 -295 -356 -267
Repayment of Debt
132 1.83 -924 -78 -28 -113 -213 -370
Repurchase of Preferred Equity
0.00 -91 -721 - - - - -
Repurchase of Common Equity
-12 -309 -56 -15 -51 -81 -65 -98
Payment of Dividends
-208 -186 -197 -140 -125 -114 -106 -103
Issuance of Debt
0.00 242 2,010 577 35 13 29 -
Issuance of Common Equity
2.99 0.00 3.67 2.26 6.05 0.00 0.00 9.98
Effect of Exchange Rate Changes
-2.06 - -6.29 20 -8.73 -12 21 -19

Quarterly Cash Flow Statements for STERIS

This table details how cash moves in and out of STERIS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022
Net Change in Cash & Equivalents
-17 -26 -8.69 11 -18 5.14 0.26 -51 1.11 -58 -32
Net Cash From Operating Activities
333 251 304 255 291 146 281 216 206 104 232
Net Cash From Continuing Operating Activities
333 255 304 255 291 146 281 211 203 104 232
Net Income / (Loss) Continuing Operations
173 151 146 -1.00 141 116 124 187 123 -315 111
Consolidated Net Income / (Loss)
173 151 146 -1.00 141 116 124 187 123 -315 111
Depreciation Expense
126 115 113 134 141 152 138 142 138 134 139
Non-Cash Adjustments To Reconcile Net Income
7.90 35 0.20 249 20 18 14 -2.64 4.80 502 22
Changes in Operating Assets and Liabilities, net
26 -47 45 -128 -15 -140 5.75 -116 -61 -220 -40
Net Cash From Investing Activities
-124 -105 688 -96 -119 -606 -67 -78 -98 -98 -109
Net Cash From Continuing Investing Activities
-124 -105 688 -96 -119 -606 -67 -78 -98 -98 -109
Purchase of Property, Plant & Equipment
-89 -102 -108 -91 -119 -83 -67 -71 -92 -83 -116
Acquisitions
-36 -3.81 -14 -6.50 - -540 0.00 -8.55 -19 -15 0.00
Sale of Property, Plant & Equipment
0.00 - 0.00 0.01 0.02 7.36 0.01 2.42 11 0.04 1.29
Divestitures
1.52 0.35 810 - - 9.46 0.00 - 1.40 - 5.23
Net Cash From Financing Activities
-214 -181 -999 -144 -198 470 -214 -192 -120 -45 -141
Net Cash From Continuing Financing Activities
-214 -181 -999 -144 -198 470 -214 -192 -120 -45 -141
Repayment of Debt
282 -92 -891 173 248 -14 -14 142 -15 -51 -75
Repurchase of Common Equity
-100 -46 -64 -0.33 -2.23 -0.49 -8.72 -155 -84 -45 -25
Payment of Dividends
-58 -56 -52 -51 -59 -51 -47 -48 -48 -47 -43
Issuance of Debt
-338 14 5.59 -266 -387 536 -145 25 117 98 1.22
Effect of Exchange Rate Changes
-12 9.46 -1.33 - 7.50 -4.93 -0.64 - - - -13

Annual Balance Sheets for STERIS

This table presents STERIS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020 3/31/2019 3/31/2018
Total Assets
11,064 10,822 11,424 6,574 5,441 5,073 5,200
Total Current Assets
2,869 2,011 1,879 1,212 1,224 1,054 990
Cash & Equivalents
207 208 348 221 320 221 202
Accounts Receivable
1,008 865 799 609 586 555 528
Inventories, net
675 604 575 315 264 208 206
Prepaid Expenses
174 176 157 67 54 60 54
Other Current Nonoperating Assets
805 158 - - - - -
Plant, Property, & Equipment, net
1,765 1,633 1,553 1,235 1,112 1,032 1,011
Total Noncurrent Assets
6,429 7,178 7,992 4,127 3,105 2,988 3,200
Goodwill
4,071 3,879 4,404 3,026 2,356 2,323 2,434
Intangible Assets
2,119 2,077 3,329 898 565 605 727
Other Noncurrent Operating Assets
239 244 259 203 183 60 39
Total Liabilities & Shareholders' Equity
11,064 10,822 11,424 6,574 5,441 5,073 5,200
Total Liabilities
4,748 4,735 4,879 2,683 2,023 1,887 1,983
Total Current Liabilities
931 862 922 578 504 465 398
Short-Term Debt
86 60 143 0.00 20 0.00 -
Accounts Payable
252 264 226 157 149 153 136
Accrued Expenses
320 298 307 221 192 188 168
Current Deferred & Payable Income Tax Liabilities
14 40 27 28 14 15 0.38
Current Employee Benefit Liabilities
165 118 184 150 128 109 94
Other Current Liabilities
31 30 36 23 - - -
Other Current Nonoperating Liabilities
64 51 - - - - -
Total Noncurrent Liabilities
3,817 3,873 3,957 2,105 1,519 1,422 1,585
Long-Term Debt
3,120 3,019 2,945 1,651 1,151 1,183 1,316
Capital Lease Obligations
146 140 155 130 114 0.00 -
Noncurrent Deferred & Payable Income Tax Liabilities
480 618 781 237 164 151 160
Other Noncurrent Operating Liabilities
72 76 76 88 90 88 109
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
6,315 6,087 6,545 3,891 3,418 3,186 3,217
Total Preferred & Common Equity
6,302 6,077 6,532 3,881 3,405 3,178 3,206
Total Common Equity
6,302 6,077 6,532 3,881 3,405 3,178 3,206
Common Stock
4,543 4,486 4,743 2,003 1,982 1,999 2,048
Retained Earnings
2,088 1,912 1,999 1,939 1,659 1,339 1,146
Accumulated Other Comprehensive Income / (Loss)
-329 -321 -210 -61 -235 -160 12
Noncontrolling Interest
13 9.97 12 10 13 7.99 11

Quarterly Balance Sheets for STERIS

This table presents STERIS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022
Total Assets
10,008 10,242 10,109 11,064 11,435 11,281 10,784 10,822 10,800 10,490 11,188
Total Current Assets
1,898 1,938 1,940 2,869 2,219 2,174 2,031 2,011 1,977 1,888 1,848
Cash & Equivalents
155 172 198 207 196 214 209 208 259 258 316
Accounts Receivable
915 923 893 1,008 964 940 888 865 823 780 764
Inventories, net
650 689 699 675 856 821 769 604 694 645 620
Prepaid Expenses
178 153 151 174 204 199 166 176 200 205 147
Other Current Nonoperating Assets
0.00 0.00 0.00 805 - - - 158 - - -
Plant, Property, & Equipment, net
1,922 1,930 1,834 1,765 1,844 1,744 1,726 1,633 1,671 1,572 1,573
Total Noncurrent Assets
6,189 6,375 6,334 6,429 7,372 7,363 7,027 7,178 7,152 7,029 7,767
Goodwill
4,044 4,151 4,057 4,071 4,112 4,040 3,887 3,879 3,853 3,705 4,321
Intangible Assets
1,923 2,004 2,049 2,119 2,987 3,058 2,865 2,077 3,031 3,077 3,193
Other Noncurrent Operating Assets
222 220 228 239 273 265 275 244 268 246 253
Total Liabilities & Shareholders' Equity
10,008 10,242 10,109 11,064 11,435 11,281 10,784 10,822 10,800 10,490 11,188
Total Liabilities
3,580 3,632 3,738 4,748 5,007 5,091 4,606 4,735 4,751 4,676 4,769
Total Current Liabilities
891 805 834 931 914 873 887 862 796 873 908
Short-Term Debt
125 80 80 86 78 71 63 60 60 151 151
Accounts Payable
238 235 232 252 277 294 261 264 242 233 229
Accrued Expenses
335 307 287 320 318 307 333 298 303 304 318
Current Deferred & Payable Income Tax Liabilities
0.00 5.85 57 14 25 32 64 40 25 17 38
Current Employee Benefit Liabilities
161 147 149 165 179 136 132 118 131 134 138
Other Current Liabilities
32 31 30 31 37 34 34 30 35 34 36
Other Current Nonoperating Liabilities
0.00 0.00 0.00 64 - - - 51 - - -
Total Noncurrent Liabilities
2,689 2,826 2,904 3,817 4,093 4,218 3,719 3,873 3,955 3,803 3,861
Long-Term Debt
2,039 2,156 2,236 3,120 3,231 3,366 2,860 3,019 3,002 2,874 2,846
Capital Lease Obligations
124 133 139 146 163 162 165 140 156 143 150
Noncurrent Deferred & Payable Income Tax Liabilities
453 463 456 480 621 613 618 618 725 710 791
Other Noncurrent Operating Liabilities
73 74 72 72 78 77 77 76 73 76 73
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
6,429 6,610 6,370 6,315 6,428 6,189 6,178 6,087 6,049 5,813 6,419
Total Preferred & Common Equity
6,416 6,593 6,355 6,302 6,415 6,178 6,168 6,077 6,038 5,802 6,408
Total Common Equity
6,416 6,593 6,355 6,302 6,415 6,178 6,168 6,077 6,038 5,802 6,408
Common Stock
4,405 4,491 4,500 4,543 4,534 4,519 4,498 4,486 4,632 4,705 4,739
Retained Earnings
2,386 2,268 2,178 2,088 2,134 2,046 1,981 1,912 1,771 1,695 2,057
Accumulated Other Comprehensive Income / (Loss)
-374 -166 -323 -329 -253 -387 -311 -321 -364 -598 -388
Noncontrolling Interest
12 17 16 13 13 11 10 9.97 10 11 12

Annual Metrics And Ratios for STERIS

This table displays calculated financial ratios and metrics derived from STERIS's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017
Period end date 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020 3/31/2019 3/31/2018 3/31/2017
Growth Metrics
- - - - - - - -
Revenue Growth
13.28% 7.41% 35.91% 2.53% 8.94% 6.19% 0.28% 0.00%
EBITDA Growth
5.68% 24.63% 39.03% 5.12% 15.05% 9.59% 39.93% 0.00%
EBIT Growth
7.48% 72.74% -17.74% 2.91% 30.19% 2.08% 76.99% 0.00%
NOPAT Growth
1.76% 74.56% -11.88% -4.25% 29.39% 3.32% 142.39% 0.00%
Net Income Growth
259.20% -56.43% -38.80% -2.69% 33.84% 4.50% 163.60% 0.00%
EPS Growth
256.07% -56.85% -46.44% -2.73% 34.08% 4.72% 164.84% 0.00%
Operating Cash Flow Growth
28.58% 10.53% -0.70% 16.78% 9.46% 17.89% 7.91% 0.00%
Free Cash Flow Firm Growth
-101.33% 156.74% -458.72% -432.34% -63.41% 113.30% 0.00% 0.00%
Invested Capital Growth
8.53% -14.89% 73.17% 24.37% 5.90% -4.46% 0.00% 0.00%
Revenue Q/Q Growth
-4.97% -5.17% -0.58% 1.65% 1.84% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
1.64% 72.53% 16.75% -0.48% 1.99% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
3.14% 493.45% -0.09% -2.09% 2.61% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
-3.12% 656.23% 5.78% -8.50% 3.97% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
-33.09% 463.64% -12.50% -8.43% 3.75% 0.00% 0.00% 0.00%
EPS Q/Q Growth
-33.28% 635.00% -14.19% -8.13% 3.70% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
4.18% 6.18% -2.30% -1.62% 3.56% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
-46.17% 239.73% 6.91% -12.85% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
-10.15% -10.80% -2.96% -0.72% -1.66% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - -
Gross Margin
43.17% 43.66% 44.59% 43.22% 43.55% 42.23% 41.71% 39.28%
EBITDA Margin
27.58% 29.56% 25.48% 24.91% 24.29% 23.00% 22.29% 15.97%
Operating Margin
16.27% 17.44% 11.31% 17.65% 17.72% 14.77% 15.26% 8.66%
EBIT Margin
16.49% 17.38% 10.80% 17.85% 17.78% 14.88% 15.48% 8.77%
Profit (Net Income) Margin
7.40% 2.33% 5.75% 12.77% 13.46% 10.95% 11.13% 4.23%
Tax Burden Percent
54.08% 15.55% 66.21% 76.69% 81.78% 82.58% 82.15% 59.92%
Interest Burden Percent
82.96% 86.30% 80.39% 93.30% 92.53% 89.13% 87.52% 80.57%
Effective Tax Rate
21.28% 18.24% 22.45% 23.32% 18.22% 17.42% 17.85% 40.08%
Return on Invested Capital (ROIC)
7.86% 7.40% 4.98% 8.55% 10.31% 8.01% 15.17% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-4.93% -14.94% -0.76% 6.68% 7.04% 4.66% 8.55% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-1.73% -5.73% -0.32% 2.31% 2.04% 1.50% 2.96% 0.00%
Return on Equity (ROE)
6.13% 1.68% 4.65% 10.86% 12.35% 9.52% 18.13% 0.00%
Cash Return on Invested Capital (CROIC)
-0.33% 23.50% -48.59% -13.17% 4.57% 12.57% -184.83% 0.00%
Operating Return on Assets (OROA)
7.74% 7.09% 5.07% 9.23% 10.25% 8.06% 7.80% 0.00%
Return on Assets (ROA)
3.47% 0.95% 2.70% 6.61% 7.76% 5.93% 5.61% 0.00%
Return on Common Equity (ROCE)
6.12% 1.67% 4.64% 10.82% 12.31% 9.49% 18.06% 0.00%
Return on Equity Simple (ROE_SIMPLE)
6.03% 1.74% 3.72% 10.23% 11.98% 9.59% 9.10% 0.00%
Net Operating Profit after Tax (NOPAT)
658 647 371 421 439 339 329 136
NOPAT Margin
12.81% 14.26% 8.77% 13.53% 14.49% 12.20% 12.54% 5.19%
Net Nonoperating Expense Percent (NNEP)
12.79% 22.35% 5.73% 1.87% 3.27% 3.35% 6.62% 0.00%
Cost of Revenue to Revenue
56.83% 56.34% 55.41% 56.78% 56.45% 57.77% 58.29% 60.72%
SG&A Expenses to Revenue
24.37% 24.04% 31.22% 23.53% 23.65% 24.08% 24.12% 26.10%
R&D to Revenue
2.02% 2.17% 2.05% 2.13% 2.16% 2.27% 2.32% 2.27%
Operating Expenses to Revenue
26.89% 26.22% 33.27% 25.57% 25.83% 27.46% 26.45% 30.62%
Earnings before Interest and Taxes (EBIT)
847 788 456 555 539 414 406 229
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,417 1,341 1,076 774 736 640 584 417
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
3.53 3.10 3.64 4.09 3.37 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
198.05 155.13 0.00 0.00 23.72 0.00 0.00 0.00
Price to Revenue (P/Rev)
4.32 4.15 5.62 5.10 3.79 0.00 0.00 0.00
Price to Earnings (P/E)
58.73 175.79 97.39 39.92 28.15 0.00 0.00 0.00
Dividend Yield
0.90% 0.97% 0.71% 0.84% 1.07% 1.08% 1.38% 1.68%
Earnings Yield
1.70% 0.57% 1.03% 2.51% 3.55% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.91 2.72 2.82 3.20 2.84 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
4.94 4.81 6.31 5.61 4.11 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
17.90 16.28 24.77 22.52 16.92 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
29.95 27.70 58.42 31.43 23.10 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
38.55 33.76 71.94 41.46 28.36 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
26.07 28.85 38.93 25.28 21.09 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 10.64 0.00 0.00 63.92 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.53 0.53 0.50 0.46 0.38 0.37 0.41 0.00
Long-Term Debt to Equity
0.52 0.52 0.47 0.46 0.37 0.37 0.41 0.00
Financial Leverage
0.35 0.38 0.43 0.35 0.29 0.32 0.35 0.00
Leverage Ratio
1.76 1.76 1.72 1.64 1.59 1.60 1.62 0.00
Compound Leverage Factor
1.46 1.52 1.39 1.53 1.47 1.43 1.41 0.00
Debt to Total Capital
34.67% 34.58% 33.14% 31.39% 27.31% 27.08% 29.03% 0.00%
Short-Term Debt to Total Capital
0.89% 0.64% 1.46% 0.00% 0.42% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
33.78% 33.94% 31.68% 31.39% 26.89% 27.08% 29.03% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.14% 0.11% 0.13% 0.18% 0.27% 0.18% 0.25% 0.00%
Common Equity to Total Capital
65.19% 65.31% 66.74% 68.43% 72.41% 72.74% 70.72% 0.00%
Debt to EBITDA
2.37 2.40 3.01 2.30 1.74 1.85 2.25 0.00
Net Debt to EBITDA
2.22 2.24 2.69 2.02 1.31 1.50 1.91 0.00
Long-Term Debt to EBITDA
2.30 2.35 2.88 2.30 1.72 1.85 2.25 0.00
Debt to NOPAT
5.09 4.98 8.75 4.23 2.92 3.49 4.01 0.00
Net Debt to NOPAT
4.78 4.65 7.81 3.71 2.20 2.84 3.39 0.00
Long-Term Debt to NOPAT
4.96 4.88 8.37 4.23 2.88 3.49 4.01 0.00
Altman Z-Score
4.00 3.42 3.77 4.83 4.87 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
0.19% 0.18% 0.22% 0.32% 0.32% 0.30% 0.35% 0.00%
Liquidity Ratios
- - - - - - - -
Current Ratio
3.08 2.33 2.04 2.10 2.43 2.27 2.48 0.00
Quick Ratio
1.31 1.25 1.24 1.44 1.80 1.67 1.83 0.00
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
-27 2,053 -3,618 -648 195 532 -4,003 0.00
Operating Cash Flow to CapEx
275.76% 217.90% 239.59% 288.92% 280.74% 292.97% 280.13% 252.35%
Free Cash Flow to Firm to Interest Expense
-0.19 19.02 -40.43 -17.42 4.84 11.83 -79.07 0.00
Operating Cash Flow to Interest Expense
6.74 7.01 7.65 18.55 14.66 11.99 9.04 9.53
Operating Cash Flow Less CapEx to Interest Expense
4.30 3.79 4.46 12.13 9.44 7.89 5.81 5.75
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.47 0.41 0.47 0.52 0.58 0.54 0.50 0.00
Accounts Receivable Turnover
5.49 5.45 6.00 5.20 5.31 5.14 4.96 0.00
Inventory Turnover
4.57 4.33 5.26 6.10 7.25 7.76 7.42 0.00
Fixed Asset Turnover
3.02 2.85 3.03 2.65 2.83 2.72 2.59 0.00
Accounts Payable Turnover
11.32 10.43 12.23 11.52 11.32 11.13 11.24 0.00
Days Sales Outstanding (DSO)
66.53 66.95 60.86 70.23 68.74 71.06 73.57 0.00
Days Inventory Outstanding (DIO)
79.92 84.23 69.41 59.85 50.33 47.01 49.17 0.00
Days Payable Outstanding (DPO)
32.24 34.99 29.84 31.68 32.24 32.79 32.47 0.00
Cash Conversion Cycle (CCC)
114.21 116.19 100.43 98.40 86.83 85.27 90.26 0.00
Capital & Investment Metrics
- - - - - - - -
Invested Capital
8,719 8,034 9,440 5,451 4,383 4,139 4,332 0.00
Invested Capital Turnover
0.61 0.52 0.57 0.63 0.71 0.66 1.21 0.00
Increase / (Decrease) in Invested Capital
686 -1,406 3,989 1,068 244 -193 4,332 0.00
Enterprise Value (EV)
25,373 21,834 26,659 17,433 12,454 0.00 0.00 0.00
Market Capitalization
22,215 18,814 23,751 15,863 11,476 0.00 0.00 0.00
Book Value per Share
$63.78 $61.21 $65.24 $45.47 $40.15 $37.59 $0.00 $0.00
Tangible Book Value per Share
$1.14 $1.22 ($11.99) ($0.51) $5.70 $2.96 $0.00 $0.00
Total Capital
9,667 9,305 9,788 5,672 4,703 4,369 4,533 0.00
Total Debt
3,352 3,218 3,243 1,780 1,284 1,183 1,316 0.00
Total Long-Term Debt
3,266 3,158 3,101 1,780 1,265 1,183 1,316 0.00
Net Debt
3,145 3,010 2,895 1,560 965 963 1,114 0.00
Capital Expenditures (CapEx)
353 347 286 239 210 184 163 168
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,817 1,001 751 413 421 368 390 0.00
Debt-free Net Working Capital (DFNWC)
2,024 1,210 1,100 634 740 589 591 0.00
Net Working Capital (NWC)
1,938 1,150 957 634 720 589 591 0.00
Net Nonoperating Expense (NNE)
278 541 128 24 31 35 37 25
Net Nonoperating Obligations (NNO)
2,404 1,947 2,895 1,560 965 953 1,114 0.00
Total Depreciation and Amortization (D&A)
570 553 620 219 197 226 178 188
Debt-free, Cash-free Net Working Capital to Revenue
35.36% 22.07% 17.79% 13.30% 13.88% 13.22% 14.87% 0.00%
Debt-free Net Working Capital to Revenue
39.39% 26.67% 26.04% 20.40% 24.42% 21.15% 22.56% 0.00%
Net Working Capital to Revenue
37.71% 25.34% 22.65% 20.40% 23.77% 21.15% 22.56% 0.00%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
$3.83 $1.07 $2.50 $4.66 $4.81 $3.59 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
197.80M 197.30M 200.16M 170.74M 84.92M 84.54M 0.00 0.00
Adjusted Diluted Earnings per Share
$3.81 $1.07 $2.48 $4.63 $4.76 $3.56 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
197.80M 197.30M 200.16M 170.74M 84.92M 84.54M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
197.80M 197.30M 200.16M 170.74M 84.92M 84.54M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
679 647 371 418 440 365 329 171
Normalized NOPAT Margin
13.21% 14.27% 8.77% 13.46% 14.51% 13.12% 12.54% 6.53%
Pre Tax Income Margin
13.68% 15.00% 8.69% 16.65% 16.46% 13.26% 13.55% 7.07%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
5.87 7.30 5.10 14.92 13.38 9.20 8.01 5.15
NOPAT to Interest Expense
4.56 5.99 4.14 11.31 10.90 7.54 6.49 3.04
EBIT Less CapEx to Interest Expense
3.42 4.08 1.90 8.50 8.16 5.11 4.78 1.37
NOPAT Less CapEx to Interest Expense
2.11 2.77 0.95 4.89 5.68 3.45 3.26 -0.73
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
54.82% 175.56% 81.05% 35.38% 30.62% 37.44% 36.48% 93.20%
Augmented Payout Ratio
57.92% 467.17% 104.02% 39.07% 43.19% 64.18% 58.94% 181.34%

Quarterly Metrics And Ratios for STERIS

This table displays calculated financial ratios and metrics derived from STERIS's official financial filings.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
5.61% 7.33% 8.12% 15.87% 6.72% 3.14% 2.33% 13.46% 0.58% 0.30% 19.42%
EBITDA Growth
1.24% -4.41% -5.55% -56.66% 12.95% 302.27% 13.69% 147.96% 0.72% -173.95% 287.79%
EBIT Growth
8.44% 11.29% 3.27% -66.40% 20.99% 162.81% 26.34% 414.76% -8.03% -372.49% 2,299.93%
NOPAT Growth
4.73% 14.93% -4.32% -70.49% 20.95% 169.22% 19.11% 509.41% -7.81% -336.95% 1,196.48%
Net Income Growth
22.95% 29.93% 17.57% -100.54% 14.29% 136.91% 11.77% 259.18% -13.82% -552.76% 605.68%
EPS Growth
23.24% 30.17% 16.80% -101.06% 14.52% 136.83% 13.64% 208.20% -12.68% -556.52% 558.33%
Operating Cash Flow Growth
14.28% 71.62% 8.04% 18.08% 41.67% 40.71% 21.31% 25.66% -15.86% -39.40% 137.87%
Free Cash Flow Firm Growth
355.44% 233.46% 66.78% -123.65% -160.03% -184.60% -34.81% 153.36% 121.27% 116.62% 110.23%
Invested Capital Growth
-11.79% -8.01% -4.76% 8.53% 7.75% 9.76% -2.08% -14.89% -7.41% -10.70% -4.17%
Revenue Q/Q Growth
3.13% 3.86% 14.63% -20.03% 4.81% 4.63% 22.85% -20.78% 1.29% 3.81% -4.48%
EBITDA Q/Q Growth
13.32% 3.60% -17.55% 6.19% 7.00% 2.37% -62.16% 172.56% 291.61% -157.53% -3.45%
EBIT Q/Q Growth
15.51% 4.34% -18.25% 15.27% 18.55% -3.19% -73.40% 296.32% 161.54% -294.73% 69.06%
NOPAT Q/Q Growth
8.95% 15.17% -24.41% 15.34% 19.55% -4.11% -76.69% 352.60% 168.42% -265.00% 94.29%
Net Income Q/Q Growth
14.63% 3.87% 14,625.05% -100.71% 21.14% -6.01% -33.79% 51.60% 139.12% -384.62% 112.77%
EPS Q/Q Growth
15.89% 3.42% 7,400.00% -101.41% 22.41% -7.20% -33.51% 51.61% 139.37% -386.36% 80.33%
Operating Cash Flow Q/Q Growth
32.75% -17.45% 19.21% -12.51% 99.35% -48.03% 30.27% 4.97% 98.01% -55.20% 34.95%
Free Cash Flow Firm Q/Q Growth
41.82% 61.93% 218.29% 7.31% 25.90% -302.36% -83.23% 138.70% 4.42% 55.93% 113.58%
Invested Capital Q/Q Growth
-2.80% 2.09% -1.06% -10.15% 1.36% 5.70% 12.75% -10.80% 3.25% -5.70% -2.01%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
44.53% 43.55% 44.74% 40.19% 43.15% 44.11% 44.70% 42.47% 42.89% 44.34% 44.77%
EBITDA Margin
27.27% 24.82% 24.88% 34.59% 28.45% 27.87% 28.48% 92.48% 26.88% -14.21% 25.64%
Operating Margin
17.90% 16.53% 14.50% 21.97% 17.45% 15.47% 16.71% 77.69% 15.69% -25.52% 13.70%
EBIT Margin
18.08% 16.15% 16.07% 22.54% 17.61% 15.57% 16.83% 77.72% 15.53% -25.57% 13.63%
Profit (Net Income) Margin
12.64% 11.38% 11.37% -0.09% 10.86% 9.40% 10.46% 19.41% 10.14% -26.26% 9.58%
Tax Burden Percent
75.75% 77.57% 83.04% -0.47% 74.34% 74.65% 74.22% 26.04% 76.92% 94.65% 82.07%
Interest Burden Percent
92.30% 90.83% 85.22% 85.65% 82.96% 80.84% 83.75% 95.91% 84.88% 108.51% 85.62%
Effective Tax Rate
24.21% 22.32% 20.15% 20.08% 21.62% 22.49% 21.71% 11.24% 23.08% 0.00% 17.93%
Return on Invested Capital (ROIC)
8.02% 7.44% 6.85% 10.77% 6.85% 6.03% 6.52% 35.80% 6.16% -9.23% 5.68%
ROIC Less NNEP Spread (ROIC-NNEP)
7.55% 6.74% 6.75% 1.72% 5.67% 5.01% 5.43% 16.09% 5.39% -12.51% 5.02%
Return on Net Nonoperating Assets (RNNOA)
3.18% 2.94% 2.76% 0.60% 2.84% 2.63% 2.46% 6.17% 2.58% -6.21% 2.28%
Return on Equity (ROE)
11.19% 10.38% 9.62% 11.37% 9.68% 8.66% 8.99% 41.97% 8.74% -15.44% 7.96%
Cash Return on Invested Capital (CROIC)
19.99% 15.68% 12.24% -0.33% 4.83% 2.93% 9.44% 23.50% 6.45% 11.04% 8.99%
Operating Return on Assets (OROA)
9.10% 7.99% 8.05% 10.58% 7.42% 6.58% 6.99% 31.70% 6.61% -10.98% 5.59%
Return on Assets (ROA)
6.37% 5.63% 5.70% -0.04% 4.57% 3.97% 4.34% 7.92% 4.31% -11.28% 3.93%
Return on Common Equity (ROCE)
11.17% 10.36% 9.60% 11.35% 9.66% 8.64% 8.97% 41.90% 8.73% -15.42% 7.94%
Return on Equity Simple (ROE_SIMPLE)
7.31% 6.62% 6.32% 0.00% 8.85% 8.91% 1.93% 0.00% -0.48% -0.16% 5.86%
Net Operating Profit after Tax (NOPAT)
186 171 148 196 177 148 155 664 147 -214 130
NOPAT Margin
13.56% 12.84% 11.58% 17.56% 13.68% 11.99% 13.08% 68.96% 12.07% -17.87% 11.24%
Net Nonoperating Expense Percent (NNEP)
0.47% 0.70% 0.10% 9.06% 1.17% 1.02% 1.09% 19.71% 0.77% 3.28% 0.65%
Return On Investment Capital (ROIC_SIMPLE)
2.13% - - - 1.79% - - - - - -
Cost of Revenue to Revenue
55.47% 56.45% 55.26% 59.81% 56.85% 55.89% 55.30% 57.53% 57.11% 55.66% 55.23%
SG&A Expenses to Revenue
24.48% 24.78% 26.23% 13.63% 23.76% 26.52% 25.90% 13.26% 25.09% 26.92% 28.93%
R&D to Revenue
2.00% 2.03% 2.00% 2.26% 1.95% 2.12% 2.09% 2.42% 2.10% 2.08% 2.14%
Operating Expenses to Revenue
26.63% 27.02% 30.24% 18.22% 25.70% 28.64% 27.99% -35.22% 27.20% 69.87% 31.08%
Earnings before Interest and Taxes (EBIT)
248 215 206 252 229 193 199 749 189 -307 158
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
374 330 318 386 369 345 337 891 327 -171 296
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.16 3.63 3.42 3.53 3.35 3.48 3.56 3.10 3.02 2.83 3.17
Price to Tangible Book Value (P/TBV)
45.20 54.56 87.25 198.05 0.00 0.00 0.00 155.13 0.00 0.00 0.00
Price to Revenue (P/Rev)
3.76 4.49 4.15 4.32 4.59 4.67 4.82 4.15 3.82 3.44 4.26
Price to Earnings (P/E)
43.39 55.01 54.27 58.73 37.96 39.04 184.26 175.79 0.00 0.00 53.92
Dividend Yield
1.06% 0.88% 0.95% 0.90% 0.91% 0.89% 0.84% 0.97% 0.98% 1.07% 0.85%
Earnings Yield
2.30% 1.82% 1.84% 1.70% 2.63% 2.56% 0.54% 0.57% 0.00% 0.00% 1.85%
Enterprise Value to Invested Capital (EV/IC)
2.62 2.97 2.78 2.91 2.56 2.60 2.75 2.72 2.36 2.22 2.50
Enterprise Value to Revenue (EV/Rev)
4.16 4.91 4.58 4.94 5.30 5.40 5.45 4.81 4.44 4.05 4.85
Enterprise Value to EBITDA (EV/EBITDA)
16.22 18.96 17.21 17.90 12.77 13.09 18.00 16.28 27.31 25.54 19.68
Enterprise Value to EBIT (EV/EBIT)
25.07 29.85 28.10 29.95 18.12 18.70 29.98 27.70 159.82 129.57 40.73
Enterprise Value to NOPAT (EV/NOPAT)
32.91 38.79 36.80 38.55 21.57 22.21 37.03 33.76 0.00 0.00 51.82
Enterprise Value to Operating Cash Flow (EV/OCF)
19.64 23.75 24.08 26.07 26.55 29.30 30.85 28.85 29.78 25.74 28.29
Enterprise Value to Free Cash Flow (EV/FCFF)
12.29 18.14 22.15 0.00 54.87 92.68 28.79 10.64 35.13 18.96 27.26
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.36 0.36 0.39 0.53 0.54 0.58 0.50 0.53 0.53 0.55 0.49
Long-Term Debt to Equity
0.34 0.35 0.37 0.52 0.53 0.57 0.49 0.52 0.52 0.52 0.47
Financial Leverage
0.42 0.44 0.41 0.35 0.50 0.52 0.45 0.38 0.48 0.50 0.45
Leverage Ratio
1.67 1.68 1.66 1.76 1.78 1.81 1.74 1.76 1.77 1.80 1.79
Compound Leverage Factor
1.54 1.53 1.42 1.51 1.48 1.47 1.46 1.69 1.51 1.95 1.53
Debt to Total Capital
26.24% 26.38% 27.82% 34.67% 35.07% 36.77% 33.33% 34.58% 34.72% 35.28% 32.90%
Short-Term Debt to Total Capital
1.43% 0.89% 0.91% 0.89% 0.79% 0.72% 0.68% 0.64% 0.65% 1.68% 1.58%
Long-Term Debt to Total Capital
24.81% 25.49% 26.91% 33.78% 34.28% 36.05% 32.64% 33.94% 34.08% 33.59% 31.32%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.14% 0.19% 0.18% 0.14% 0.13% 0.11% 0.11% 0.11% 0.11% 0.13% 0.12%
Common Equity to Total Capital
73.61% 73.43% 72.00% 65.19% 64.80% 63.12% 66.56% 65.31% 65.17% 64.60% 66.98%
Debt to EBITDA
1.65 1.72 1.76 2.37 1.79 1.89 2.24 2.40 4.14 4.18 2.67
Net Debt to EBITDA
1.54 1.59 1.62 2.22 1.69 1.78 2.08 2.24 3.81 3.84 2.41
Long-Term Debt to EBITDA
1.56 1.66 1.70 2.30 1.75 1.86 2.19 2.35 4.06 3.98 2.55
Debt to NOPAT
3.36 3.52 3.77 5.09 3.02 3.22 4.60 4.98 -27.67 -129.03 7.04
Net Debt to NOPAT
3.13 3.26 3.46 4.78 2.85 3.02 4.29 4.65 -25.44 -118.52 6.33
Long-Term Debt to NOPAT
3.17 3.40 3.64 4.96 2.95 3.15 4.50 4.88 -27.15 -122.88 6.70
Altman Z-Score
4.48 4.98 4.50 3.82 3.45 3.39 3.73 3.41 3.17 2.81 3.39
Noncontrolling Interest Sharing Ratio
0.20% 0.22% 0.21% 0.19% 0.18% 0.19% 0.17% 0.18% 0.18% 0.17% 0.17%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.13 2.41 2.33 3.08 2.43 2.49 2.29 2.33 2.48 2.16 2.03
Quick Ratio
1.20 1.36 1.31 1.31 1.27 1.32 1.24 1.25 1.36 1.19 1.19
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,330 938 579 -490 -521 -703 347 2,070 867 831 533
Operating Cash Flow to CapEx
373.02% 246.07% 281.03% 278.51% 244.90% 192.39% 422.14% 312.63% 253.87% 125.49% 202.14%
Free Cash Flow to Firm to Interest Expense
69.65 47.68 19.06 -13.56 -13.37 -19.02 10.73 67.65 30.37 31.80 23.49
Operating Cash Flow to Interest Expense
17.43 12.75 10.00 7.06 7.48 3.96 8.69 7.05 7.20 3.97 10.22
Operating Cash Flow Less CapEx to Interest Expense
12.76 7.57 6.44 4.52 4.42 1.90 6.63 4.80 4.36 0.81 5.16
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.50 0.49 0.50 0.47 0.42 0.42 0.42 0.41 0.43 0.43 0.41
Accounts Receivable Turnover
5.75 5.72 5.88 5.49 5.24 5.35 5.53 5.45 6.07 6.19 6.33
Inventory Turnover
4.06 4.01 4.05 4.57 3.40 3.54 3.70 4.33 4.10 4.33 4.39
Fixed Asset Turnover
2.87 2.90 2.94 3.02 2.66 2.77 2.77 2.85 3.00 3.10 3.11
Accounts Payable Turnover
11.86 11.47 12.08 11.32 10.16 9.85 10.50 10.43 11.74 11.56 11.56
Days Sales Outstanding (DSO)
63.53 63.87 62.07 66.53 69.64 68.24 66.05 66.95 60.08 58.92 57.63
Days Inventory Outstanding (DIO)
89.95 90.91 90.07 79.92 107.22 103.10 98.61 84.23 89.09 84.35 83.09
Days Payable Outstanding (DPO)
30.78 31.83 30.22 32.24 35.92 37.06 34.76 34.99 31.08 31.56 31.58
Cash Conversion Cycle (CCC)
122.70 122.95 121.92 114.21 140.94 134.29 129.90 116.19 118.09 111.71 109.14
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
8,561 8,808 8,627 8,719 9,705 9,575 9,058 8,034 9,007 8,724 9,250
Invested Capital Turnover
0.59 0.58 0.59 0.61 0.50 0.50 0.50 0.52 0.51 0.52 0.51
Increase / (Decrease) in Invested Capital
-1,144 -767 -431 686 698 851 -192 -1,406 -721 -1,045 -403
Enterprise Value (EV)
22,435 26,133 23,985 25,373 24,804 24,866 24,876 21,834 21,227 19,345 23,170
Market Capitalization
20,290 23,919 21,713 22,215 21,515 21,469 21,987 18,814 18,259 16,424 20,327
Book Value per Share
$65.00 $66.86 $64.25 $63.78 $64.93 $62.54 $62.53 $61.21 $60.49 $58.01 $64.02
Tangible Book Value per Share
$4.55 $4.45 $2.52 $1.14 ($6.92) ($9.31) ($5.91) $1.22 ($8.48) ($9.80) ($11.06)
Total Capital
8,716 8,980 8,825 9,667 9,900 9,788 9,267 9,305 9,266 8,982 9,567
Total Debt
2,287 2,369 2,455 3,352 3,472 3,599 3,088 3,218 3,218 3,168 3,148
Total Long-Term Debt
2,162 2,289 2,375 3,266 3,394 3,528 3,025 3,158 3,158 3,017 2,997
Net Debt
2,132 2,197 2,257 3,145 3,277 3,386 2,880 3,010 2,958 2,910 2,831
Capital Expenditures (CapEx)
89 102 108 91 119 76 67 69 81 83 115
Debt-free, Cash-free Net Working Capital (DFCFNWC)
977 1,040 988 1,817 1,188 1,158 999 1,001 981 908 774
Debt-free Net Working Capital (DFNWC)
1,132 1,212 1,186 2,024 1,384 1,372 1,208 1,210 1,240 1,166 1,091
Net Working Capital (NWC)
1,007 1,132 1,106 1,938 1,305 1,301 1,144 1,150 1,180 1,015 940
Net Nonoperating Expense (NNE)
13 19 2.61 197 37 32 31 477 23 101 19
Net Nonoperating Obligations (NNO)
2,132 2,197 2,257 2,404 3,277 3,386 2,880 1,947 2,958 2,910 2,831
Total Depreciation and Amortization (D&A)
126 115 113 135 141 152 138 142 138 136 139
Debt-free, Cash-free Net Working Capital to Revenue
18.09% 19.53% 18.87% 35.36% 25.37% 25.17% 21.90% 22.07% 20.50% 19.01% 16.22%
Debt-free Net Working Capital to Revenue
20.96% 22.77% 22.66% 39.39% 29.55% 29.82% 26.47% 26.67% 25.93% 24.42% 22.85%
Net Working Capital to Revenue
18.65% 21.26% 21.13% 37.71% 27.87% 28.27% 25.08% 25.34% 24.67% 21.26% 19.69%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.76 $1.52 $1.47 ($0.01) $1.42 $1.17 $1.25 $1.87 $1.24 ($3.15) $1.11
Adjusted Weighted Average Basic Shares Outstanding
98.25M 98.71M 197.23M 197.80M 197.63M 197.60M 197.56M 197.30M 198.57M 199.65M 200.03M
Adjusted Diluted Earnings per Share
$1.75 $1.51 $1.46 ($0.02) $1.42 $1.16 $1.25 $1.88 $1.24 ($3.15) $1.10
Adjusted Weighted Average Diluted Shares Outstanding
98.25M 98.71M 197.23M 197.80M 197.63M 197.60M 197.56M 197.30M 198.57M 199.65M 200.03M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
98.25M 98.71M 197.23M 197.80M 197.63M 197.60M 197.56M 197.30M 198.57M 199.65M 200.03M
Normalized Net Operating Profit after Tax (NOPAT)
188 173 169 217 178 148 155 665 147 129 130
Normalized NOPAT Margin
13.69% 13.00% 13.18% 19.42% 13.68% 11.99% 13.09% 68.99% 12.07% 10.74% 11.24%
Pre Tax Income Margin
16.69% 14.67% 13.70% 19.30% 14.61% 12.59% 14.09% 74.54% 13.19% -27.74% 11.67%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
12.98 10.91 6.77 6.97 5.87 5.22 6.15 24.47 6.61 -11.75 6.95
NOPAT to Interest Expense
9.74 8.68 4.88 5.43 4.56 4.02 4.79 21.71 5.14 -8.21 5.73
EBIT Less CapEx to Interest Expense
8.31 5.73 3.21 4.43 2.81 3.16 4.10 22.21 3.78 -14.92 1.90
NOPAT Less CapEx to Interest Expense
5.06 3.49 1.32 2.89 1.50 1.96 2.73 19.45 2.30 -11.38 0.68
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
46.31% 49.98% 53.10% 54.82% 36.03% 35.17% 159.18% 175.56% -622.55% -1,968.20% 48.10%
Augmented Payout Ratio
91.38% 75.90% 69.84% 57.92% 65.26% 80.20% 405.39% 467.17% -1,248.37% -3,050.28% 66.69%

Frequently Asked Questions About STERIS's Financials

When does STERIS's financial year end?

According to the most recent income statement we have on file, STERIS's fiscal year ends in March. Their fiscal year 2024 ended on March 31, 2024.

How has STERIS's net income changed over the last 7 years?

STERIS's net income appears to be on an upward trend, with a most recent value of $380.08 million in 2024, rising from $110.63 million in 2017. The previous period was $105.81 million in 2023. Find out what analysts predict for STERIS in the coming months.

What is STERIS's operating income?
STERIS's total operating income in 2024 was $836.12 million, based on the following breakdown:
  • Total Gross Profit: $2.22 billion
  • Total Operating Expenses: $1.38 billion
How has STERIS revenue changed over the last 7 years?

Over the last 7 years, STERIS's total revenue changed from $2.61 billion in 2017 to $5.14 billion in 2024, a change of 96.7%.

How much debt does STERIS have?

STERIS's total liabilities were at $4.75 billion at the end of 2024, a 0.3% increase from 2023, and a 139.4% increase since 2018.

How much cash does STERIS have?

In the past 6 years, STERIS's cash and equivalents has ranged from $201.53 million in 2018 to $348.32 million in 2022, and is currently $207.02 million as of their latest financial filing in 2024.

How has STERIS's book value per share changed over the last 7 years?

Over the last 7 years, STERIS's book value per share changed from 0.00 in 2017 to 63.78 in 2024, a change of 6,377.8%.



This page (NYSE:STE) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners